New technology designed to analyse large numbers of marine microbes could lead to more efficient and greener ways to manufacture drugs to treat patients with diseases such as epilepsy, diabetes and flu. Researchers at Heriot-Watt University and the Plymouth Marine Laboratory are working with Ingenza, an Edinburgh-based company, to identify new enzymes for use in the pharmaceutical industry.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.